Msm2000 Premium

Methylsulfonylmethane


Vigen Medical
Human Otc Drug
NDC 82437-020
Msm2000 Premium also known as Methylsulfonylmethane is a human otc drug labeled by 'Vigen Medical'. National Drug Code (NDC) number for Msm2000 Premium is 82437-020. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Msm2000 Premium drug includes Dimethyl Sulfone - 500 mg/506mg . The currest status of Msm2000 Premium drug is Active.

Drug Information:

Drug NDC: 82437-020
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Msm2000 Premium
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Methylsulfonylmethane
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Vigen Medical
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:DIMETHYL SULFONE - 500 mg/506mg
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Dec, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Vigen medical
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:8809292030496
UPC stands for Universal Product Code.
UNII:9H4PO4Z4FT
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
82437-020-02120 BLISTER PACK in 1 CARTON (82437-020-02) / 506 mg in 1 BLISTER PACK (82437-020-01)01 Dec, 2021N/ANo
82437-020-03360 BLISTER PACK in 1 CARTON (82437-020-03) / 506 mg in 1 BLISTER PACK (82437-020-01)01 Dec, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose to your healthy joints and cartilages

Product Elements:

Msm2000 premium methylsulfonylmethane dimethyl sulfone dimethyl sulfone ascorbic acid

Indications and Usage:

Uses ■ it can help to maintain joints and cartilages healthy

Warnings:

Warnings ■ do not consume if there is anything wrong with product before ingestion. ■ if you have specific constitution or allergic, please check the ingredients before ingestion. ■ if a child swallows tablets, it can get caught in the throat, so care must be taken not to swallow them. ■ infants, pregnant women, lactating women, disease holders, or those taking drugs should consult a doctor, pharmacist, etc. before ingestion. ■ please be careful because you should not take the "dehumidifier" packaged separately for food quality control. ■ consult with an expert in the case of an abnormal case.

Dosage and Administration:

Directions ■ take 2 tablets twice a day with sufficient water.

Package Label Principal Display Panel:

Package label 82437-020-02 : 120 tablets image of carton

Package label 82437-020-03 : 360 tablets image of carton

Further Questions:

Questions ■ customer call +82-1644-7582


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.